Promoter Docon fully releases pledge on 51.02% Thyrocare shares

Pledge ReleasedPledge Above 50pctOwnership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹624.90

prior close

₹622.45

announcement price

In-mkt

timing

Nifty Microcap 250market+0.1%-0.9% vs market

Healthcare Service Provider peers, median of 27sector+0.7%-1.5% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.7

15m

-0.7

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.1-0.9+0.7-1.5

Next day

-2.4+0.5-2.9+1.7-4.1

-7.2-0.1-7.1+0.3-7.5

-9.3+0.4-9.7-0.1-9.2

-9.4+0.7-10.1+0.0-9.4

-6.2+0.9-7.2+1.9-8.1

-3.1+1.1-4.2+2.6-5.7

15d

-7.8+1.6-9.5+2.0-9.9

-10.5-0.7-9.7+4.3-14.8

-24.8-3.2-21.6-3.2-21.6

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Docon Technologies, promoter of Thyrocare, fully released its pledge on 7,94,69,696 equity shares (51.02% of share capital) held in favour of Catalyst Trusteeship. The pledge backed NCDs worth INR 10,500 million issued by API Holdings (Docon's parent), which were fully redeemed on August 14, 2026. Docon's 51.02% stake in Thyrocare remains unchanged. No promoter shares are now encumbered.

Likely market impact

All promoter shares are now unencumbered, removing pledge overhang risk. Margin call risk gone, potentially positive for stock.